A coalition to drive personalized medicine forward

Area of Science:

• Genomics and Bioinformatics
• Health Policy and Management
• Biotechnology and Pharmaceutical Sciences

Background:

• Personalized medicine adoption faces multifaceted challenges including technological, infrastructural, and regulatory hurdles.
• Existing healthcare and business models require significant adaptation for genetically defined markets.
• Ethical and legal considerations surrounding genetic information are critical for widespread implementation.

Purpose of the Study:

• To highlight the systems-level nature of personalized medicine adoption.
• To underscore the necessity for a unified, multi-stakeholder approach to policy development.
• To introduce the Personalized Medicine Coalition as a collaborative platform.

Main Methods:

• Analysis of key components required for personalized medicine.
• Identification of barriers to adoption and the need for harmonization.
• Description of the formation and objectives of the Personalized Medicine Coalition.

Main Results:

• Personalized medicine's success hinges on integrating technological, clinical, and economic advancements.
• A fragmented approach by individual stakeholders is insufficient for widespread adoption.
• The Personalized Medicine Coalition serves as a crucial forum for policy consensus and education.

Conclusions:

• Achieving widespread personalized medicine necessitates a coordinated, nationwide policy consensus.
• Collaboration among diverse stakeholders including industry, academia, and government is essential.
• The Personalized Medicine Coalition is established to facilitate this collaborative effort and advance the field.